NCT04615013 2026-04-16NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerM.D. Anderson Cancer CenterPhase 1 Recruiting24 enrolled
NCT04895709 2026-04-13A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsBristol-Myers SquibbPhase 1/2 Recruiting949 enrolled
NCT05281471 2026-03-18Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Genelux CorporationPhase 3 Recruiting186 enrolled
NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 2 FDA